Transgenic Mice That Overexpress Mouse Apolipoprotein B

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Biological Chemistry

• Publication date

  1996-05-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.271.20.11963PMID 8662599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.

  1995cited by this paper
• A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.

  1995cited by this paper
• Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL.

  1995cited by this paper
• Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes.

  1995cited by this paper
• Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.

  1994cited by this paper
• Transgenic mice expressing human apoB100 and apoB48.

  1994cited by this paper
• Expression of P1 DNA in mammalian cells and transgenic mice.

  1994cited by this paper
• Regulation and expression of the human apolipoprotein E gene in transgenic mice

  1993cited by this paper
• Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein.

  1993cited by this paper
• Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

  1993cited by this paper
• Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes.

  1993cited by this paper
• Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100.

  1992cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-1992. An eight-month-old boy with diarrhea and failure to thrive.

  1992cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

  1987cited by this paper
• Complete cDNA and derived protein sequence of human apolipoprotein B-100.

  1986cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• Biosynthesis and Metabolism of ApoB-Containing Lipoproteins.

  2024cites this paper
• Fitm2 is required for ER homeostasis and normal function of murine liver

  2023cites this paper
• Defect in cytosolic Neu2 sialidase abrogates lipid metabolism and impairs muscle function in vivo

  2022cites this paper
• In Vitro Effects of Salvinorina on mRNA Expression of Liver

  2017cites this paper
• Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin‐deficient mice

  2015cites this paper
• Function and regulation of the mono-ADP-ribosyltransferase ARTD10.

  2015cites this paper
• Endogenous ADP-Ribosylation

  2015cites this paper
• Atherosclerosis Divergent Effects of the Catalytic and Bridging Functions of Hepatic Lipase on

  2013cites this paper
• Intestinal Lipid Metabolism

  2012cites this paper
• Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.

  2011cites this paper
• The role of the aryl hydrocarbon receptor and the liver X receptor in gene regulation and metabolic homeostasis

  2009cites this paper
• CHAPTER 2 – Regulation and Clearance of Apolipoprotein B–Containing Lipoproteins

  2009cites this paper
• Effect of Curcuma kwangsiensis polysaccharides on blood lipid profiles and oxidative stress in high-fat rats.

  2009cites this paper
• ANDROGENS INDUCE GENDER- & DOSE- SPECIFIC EFFECTS ON ATHEROGENESIS

  2009cites this paper
• The expression of the human apolipoprotein genes and their regulation by PPARs

  2008cites this paper
• Roles of PPARs on regulating myocardial energy and lipid homeostasis

  2007cites this paper
• Absence of VLDL secretion does not affect alpha-tocopherol content in peripheral tissues.

  2006cites this paper
• Artificial chromosome-based transgenes in the study of genome function

  2006cites this paper
• Absence of VLDL secretion does not affect α-tocopherol content in peripheral tissues Published, JLR Papers in Press, May 18, 2006.

  2006cites this paper
• Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis

  2005cites this paper
• Complex control of mouse apolipoprotein B gene expression revealed by targeted duplication.

  2005cites this paper
• The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient “apoB-48-only” and “apoB-100-only” mice Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300459-JLR200

  2004influential citation
• Divergent Effects of the Catalytic and Bridging Functions of Hepatic Lipase on Atherosclerosis

  2004cites this paper
• Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice

  2003cites this paper
• Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion

  2003cites this paper
• Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.

  2003cites this paper
• Genetics and molecular biology.

  2003cites this paper
• Immunochemical evidence that human apoB differs when expressed in rodent versus human cells Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.M200413-JLR200

  2003cites this paper
• Structural, functional, and molecular characterization of the SHHF model of heart failure.

  2002cites this paper
• Differential, Tissue-specific, Transcriptional Regulation of Apolipoprotein B Secretion by Transforming Growth Factor β*

  2002cites this paper
• Signposts in the assembly of chylomicrons.

  2001cites this paper
• Intestinal bile acid transport: biology, physiology, and pathophysiology.

  2001cites this paper
• Recent Progress in the Study of Intestinal Apolipoprotein B Gene Expression

  2001cites this paper
• Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.

  2000cites this paper
• Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.

  2000cites this paper
• Les animaux génétiquement modifiés: Étude du transport des lipides et de l'athérosclérose

  2000cites this paper
• APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.

  2000cites this paper
• An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a).

  2000cites this paper
• Single-step conversion of P1 and P1 artificial chromosome clones into yeast artificial chromosomes.

  2000cites this paper
• Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice

  2000cites this paper
• Monocyte rolling in early atherogenesis: vital role in lesion development.

  1999cites this paper
• A functional polymorphism in the apolipoprotein B promoter that influences the level of plasma low density lipoprotein.

  1999cites this paper
• The DNA sequences required for apolipoprotein B expression in the heart are distinct from those required for expression in the intestine.

  1999cites this paper
• Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice.

  1999influential citation
• Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.

  1999cites this paper
• Adenovirus-mediated overexpression of microsomal triglyceride transfer protein (MTP): mechanistic studies on the role of MTP in apolipoprotein B-100 biogenesis.

  1999cites this paper
• Adenovirus-mediated overexpression of microsomal triglyceride transfer protein (MTP): mechanistic studies on the role of MTP in apolipoprotein B-100 biogenesis, by

  1999cites this paper
• Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency.

  1998cites this paper
• Expression of large genomic clones in transgenic mice: new insights into apolipoprotein B structure, function and regulation.

  1998cites this paper
• Using genetically engineered mice to understand apolipoprotein-B deficiency syndromes in humans.

  1998cites this paper
• Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

  1998cites this paper
• Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins

  1998cites this paper
• A Gene-targeted Mouse Model for Familial Hypobetalipoproteinemia

  1998cites this paper
• Genetically modified mice for the study of apolipoprotein B.

  1998cites this paper
• Genetics and molecular biology.

  1998cites this paper
• Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes.

  1998cites this paper
• Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the Apob gene.

  1998cites this paper
• Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.

  1998cites this paper
• Apolipoprotein B gene expression in a series of human apolipoprotein B transgenic mice generated with recA-assisted restriction endonuclease cleavage-modified bacterial artificial chromosomes. An intestine-specific enhancer element is located between 54 and 62 kilobases 5' to the structural gene.

  1998cites this paper
• Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage.

  1998cites this paper
• Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells.

  1998cites this paper
• Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

  1997cites this paper
• Human Apolipoprotein B Transgenic Mice Generated with 207- and 145-Kilobase Pair Bacterial Artificial Chromosomes

  1997cites this paper
• Using genetically modified mice to study apolipoprotein B.

  1996cites this paper
• Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio

  1996cites this paper
• Lipoproteins in the Heart : Evidence That the Heart Has the Capacity to Synthesize and Secrete Genes for Apolipoprotein B and Microsomal Triglyceride Transfer Protein Are Expressed

  1994cites this paper
• International Journal of Biological & Medical Research Apolipoprotein B (xbai) Allele Frequencies in an Egyptian Population: Impact on Blood Lipids a B C a B Original Article

  year unknowncites this paper
• Deficiency in Nrf2 transcription factor decreases adipose tissue Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin ‐ deficient mice mass and hepatic lipid accumulation in leptin deficient mice

  year unknowncites this paper